Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
Sk. Abdul Amin, Samima Khatun, Shovanlal Gayen, Sanjib Das, Tarun Jha
Topics & Concepts
HDAC8Cancer researchMyeloid leukemiaLeukemiaHistone deacetylaseMyeloidChemistryHistoneMedicineImmunologyGeneBiochemistryHistone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsUbiquitin and proteasome pathways